Cite
HARVARD Citation
Chernyaeva, E. et al. (n.d.). FRI0010 Pharmacokinetics, Safety and Tolerance of BCD-085, A Novel IL-17 Inhibitor, Based on The Results of Phase 1 Clinical Study in Healthy Volunteers. Annals of the rheumatic diseases. p. 429. [Online].